EDGAR Filing Documents for 0001140361-23-052634

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001140361-23-052634

Filing Date

2023-11-13

Accepted

2023-11-09 21:24:20

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	ny20009756x15_s3.htm	S-3	335235
2	EXHIBIT 5.1	ny20009756x15_ex5-1.htm	EX-5.1	6490
3	EXHIBIT 23.1	ny20009756x15_ex23-1.htm	EX-23.1	2447
4	EXHIBIT 23.2	ny20009756x15_ex23-2.htm	EX-23.2	3430
5	FILING FEES TABLE	ny20009756x15_ex107.htm	EX-FILING FEES	26449
6		logo_gyre.jpg	GRAPHIC	26811
7		logo_gyrex2.jpg	GRAPHIC	34703
8		ny20009756x15_ex5-1image01.jpg	GRAPHIC	4502
	Complete submission text file	0001140361-23-052634.txt		465922

Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130

Business Address 12730 HIGH BLUFF DRIVE, SUITE 250 SAN DIEGO CA 92130 650-266-8674

GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275466 | Film No.: 231394404
SIC: 2834 Pharmaceutical Preparations